Compliance therapy in psychotic patients: Randomised controlled trial

British Medical Journal

Volumn 312, Issue 7027, 1996, Pages 345-349

  Kemp, Roisin ^a   Hayward, Peter ^b   Applewhaite, Grantley ^a   Everitt, Brian ^b   David, Anthony ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; BEHAVIOR THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; COMPLIANCE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; SOCIAL ADAPTATION; SYMPTOM; TREATMENT OUTCOME;

EID: 0030048806     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.312.7027.345     Document Type: Article

References (35)

1. Corrigan PW, Liberman RP, Engel JD. From noncompliance to collaboration in the treatment of schizophrenia. Hosp Community Psychiatry 1990;41: 1203-11.
2. Davis JM, Andruikaitis S. The natural course of schizophrenia and effective maintenance drug treatment. J Clin Psychopharmacol 1986;6(suppl 1):2-10.
3. Coid JW. The Christopher Clunis enquiry. Psychiatric Bulletin 1994;18: 449-52.
4. Kane JM. Problems of compliance in the outpatient treatment of schizophrenia. J Clin Psychiatry 1983;44:3-6.
5. Marder SR, Mebane A, Chien CP, Winslade WJ, Swann E, Van Putten T. A comparison of patients who refuse and consent to neuroleptic treatment. Am J Psychiatry 1983;140:470-2.
6. Kelly GR, Mamon JA, Scon JE. Utility of the health belief model in examining medication compliance among psychiatric outpatients. Soc Sci Med 1987;11: 1205-11.
7. Sellwood W, Tarrier N. Demographic factors associated with extreme non-compliance in schizophrenia. Soc Psychiatry Psychiatr Epidemiol 1994;29: 172-7.
8. Van Putten T. Why do schizophrenic patients refuse to take their drugs? Arch Gen Psychiatry 1974;31:67-72.
9. Van Putten T, Crumpton E, Yale C. Drug refusal in schizophrenia and the wish to be crazy. Arch Gen Psychiatry 1976;33:1443-6.
10. Kemp R, David A. Insight and compliance. In Blackwell B, ed. Compliance and the treatment alliance in serious mental illness. Newark, NJ: Gordon and Breach Publishing Group (in press).
11. Falloon IRH. Developing and maintaining adherence to long-term drug-taking regimens, Schizophr Bull 1984;10:412-7.
12. Goldstein MJ. Psychosocial Strategies for maximising the effects of psychotropic medications for schizophrenia and mood disorder. Psychopharmacol Bull 1992;28:237-40.
13. Seltzer A, Roncari I, Garfinkel P. Effect of patient education on medication compliance. Am J Psychiatry 1980;25:638-45.
14. Streicker SK, Amdur M, Dincin J. Educating patients about psychiatric medications; failure to enhance compliance. Psychosoc Rehab J 1986;4: 15-28.
15. Boczkowski JA, Zeichner A, DeSanto N. Neuroleptic compliance among schizophrenic outpatients: an intervention outcome report. J Consult Clin Psychol 1985;53:666-71.
16. Eckman TA, Liberman RP, Phipps CC, Blair KE. Teaching medication management skills to schizophrenic patients. J Clin Psychopharmacol 1990;10:33-8.
17. Eckman TA, Wirshing WC, Marder SR, Liberman RP, Johnston-Cronk K, Zimmerman K, et al. Technique for training patients in illness self-management: a controlled trial. Am J Psychiatry 1992;149:1549-55.
18. Miller WR, Rollnick S. Motivational interviewing: preparing people to change. New York: Guilford Press, 1991.
19. Rollnick S, Heather N, Bell A. Negotiating behaviour change in medical settings: the development of brief motivational interviewing. Journal of Mental Health 1992;1:25-37.
20. Hayward P, Chan N, David A, Kemp R, Youle S, David A. Medication self-management: a preliminary report on an intervention to improve medication compliance. Journal of Mental Health 1995;4:511-7.
21. Garety PA, Kuipers L, Fowler D, Chamberlain F, Dunn G. Cognitive behavioural therapy for drug-resistant psychosis. Br J Med Psychol 1994;67:259-71.
22. Lukoff D, Lieberman RP, Neuchterlein KH. Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophr Bull 1986;12:578-602.
23. Endicott J, Spitzer RL, Fliess JL, Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976;33:766-71.
24. Nelson HE. National adult reading test (NART): test manual. Windsor: NFER-Nelson, 1982.
25. Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and validity. Psychol Med 1983;13: 177-83.
26. David AS. Insight and psychosis. Br J Psychiatry 1990;156:798-808.
27. Simpson GM, Angus JWS. Drug-induced extrapyramidal disorders. Acta Psychiatr Scand 1970;45(suppl 212):11-9.
28. Barnes TRE. A rating scale for drug-induced akathisia. Br J Psychiatry 1989;154:672-6.
29. Everitt BS. The analysis of repeated measurements: a practical review with examples. Statistician 1995;44:113-35.
30. Frison L, Pocock SJ. Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Stat Med 1992;11: 1685-704.
31. McEvoy JP, Appelbaum PS, Apperson LJ, Geller JL, Freter S. Why must some schizophrenic patients be involuntarily committed? The role of insight. Compr Psychiatry 1989;30:13-7.
32. David A, Buchanan A, Reed A, Almeida O. The assessment of insight in psychosis. Br J Psychiatry 1992;161:599-602.
33. Hoge SK, Appelbaum PS, Lawlor T, Beck JC, Litman R, Greer A, et al. A prospective, multi-center study of patients' refusal of antipsychotic medication. Arch Gen Psychiatry 1990;47:949-56.
34. Churchill DN. Compliance - how to measure it. Modem Medicine of Canada 1985;40:1068-70.
35. Babiker IE. Noncompliance in schizophrenia. Psychiatric Developments 1986; 4:329-37.